328 related articles for article (PubMed ID: 8146772)
1. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer.
Niwa Y; Iio A; Niwa G; Sakane T; Tsunematsu T; Kanoh T
J Clin Lab Immunol; 1990 Jan; 31(1):11-6. PubMed ID: 1966978
[TBL] [Abstract][Full Text] [Related]
4. Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis.
Klein A; Buskila D; Gladman D; Bruser B; Malkin A
J Rheumatol; 1990 Jan; 17(1):30-3. PubMed ID: 2313669
[TBL] [Abstract][Full Text] [Related]
5. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
8. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
[TBL] [Abstract][Full Text] [Related]
9. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
10. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
[TBL] [Abstract][Full Text] [Related]
11. [Serum level of beta-glucuronidase as potential indicator of disease activity in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)].
Falkenbach A; Unkelbach U; Gottschalk R; Kaltwasser JP
Med Klin (Munich); 1991 Sep; 86(9):465-8. PubMed ID: 1943985
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
13. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
Straub RH; Weidler C; Demmel B; Herrmann M; Kees F; Schmidt M; Schölmerich J; Schedel J
Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
[TBL] [Abstract][Full Text] [Related]
14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.
McKenna RM; Wilkins JA; Warrington RJ
J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712
[TBL] [Abstract][Full Text] [Related]
17. Raised serum APRIL levels in patients with systemic lupus erythematosus.
Koyama T; Tsukamoto H; Miyagi Y; Himeji D; Otsuka J; Miyagawa H; Harada M; Horiuchi T
Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
[TBL] [Abstract][Full Text] [Related]
18. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M
Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.
Maniwa K; Ogushi F; Tani K; Ohmoto Y; Muraguchi M; Sone S
Respirology; 2000 Dec; 5(4):315-20. PubMed ID: 11192540
[TBL] [Abstract][Full Text] [Related]
20. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
